Yohei Mano

Yohei Mano

Auto-generated profile, based on publicly available information

Yohei Mano

Department of Hepato-Biliary and Pancreatic Surgery, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in The American Journal of Surgery
Verified
Journal Article
Closed access
KYKyohei Yugawa
Kyohei Yugawa
SIShinji Itoh
Shinji Itoh
TKTakeshi Kurihara
Takeshi Kurihara
SYShohei Yoshiya
Shohei Yoshiya
YMYohei Mano
Yohei Mano
TYTomoharu Yoshizumi
Tomoharu Yoshizumi

18 October 2018 in JCI Insight
Verified
Journal Article
Open access
PDF file
SYSachiyo Yoshio
Sachiyo Yoshio
YMYohei Mano
Yohei Mano
HDHiroyoshi Doi
Hiroyoshi Doi
HSHirotaka Shoji
Hirotaka Shoji
TSTomonari Shimagaki
Tomonari Shimagaki
TKTatsuya Kanto
Tatsuya Kanto
BACKGROUND. The clearance of hepatitis B surface antigen (HBsAg) loss, defined as functional cure, is a clinical target in patients with chronic hepatitis B (CH). To understand the immune responses underlying functional cure, we evaluated cytokine and chemokine expression profiles from patients with resolving and nonresolving acute hepatitis B (AH). METHODS. We cross-sectionally evaluated 41 chemokines and cytokines at the peak of hepatitis in the sera from 41 self-limited AH patients who achieved HBsAg seroconversion, 8 AH patients who failed to clear HBsAg within 1 year after the diagnosis, 8 CH patients with hepatic flare, and 14 healthy volunteers. We longitudinally examined 41 chemokines and cytokines in the sera from 4 self-limited AH patients, 3 chimpanzees inoculated with hepatitis B virus (HBV), and 2 CH patients treated with nucleotide analogs and PEG–IFN- α , one resulting in functional cure. RESULTS. In AH patients and HBV-inoculated chimpanzees with HBsAg loss, CXCL9, CXCL10, CXCL11, CXCL13, and IL-21 were elevated at hepatitis with subsequent decline of HBsAg. Interestingly, IL-21 elevation was observed only in resolving AH patients but not in nonresolvers. CXCL13 and IL-21 elevation was not observed in CH patients who failed to attain HBsAg loss, even at hepatic flare. A concomitant increase of CXCL13 and IL-21 was significant in CH patients who attained HBsAg seroconversion with a sequential therapy. CONCLUSION. Elevation of serum CXCL9, CXCL10, CXCL11, CXCL13, and IL-21 might be a hallmark of functional cure of AH or CH patients.

1 September 2014 in American Journal of Clinical Pathology
Verified
Journal Article
Open access
PDF file
YMYohei Mano
Yohei Mano
SAShinichi Aishima
Shinichi Aishima
YKYuichiro Kubo
Yuichiro Kubo
YTYuki Tanaka
Yuki Tanaka
TMTakashi Motomura
Takashi Motomura
YOYoshinao Oda
Yoshinao Oda
Objectives:. This study investigated the association between several biological markers and fluorine-18 fluorodeoxyglucose (FDG) uptake in patients wit

15 September 2022 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
TSTomonari Shimagaki
Tomonari Shimagaki
KSKeishi Sugimachi
Keishi Sugimachi
YMYohei Mano
Yohei Mano
EOEmi Onishi
Emi Onishi
YTYuki Tanaka
Yuki Tanaka
YTYasushi Toh
Yasushi Toh
Background: Undifferentiated embryonal sarcoma of the liver (UESL) is a rare malignant mesenchymal tumor that usually occurs in children and is rarely diagnosed in adults. Case presentation: The case was a female in her late 20s who presented with a huge liver mass found upon the examination of fever. Imaging analysis showed a well-defined mass measuring 9 cm in the largest dimension in the right posterior segment of the liver. The patient underwent right hemi-hepatectomy. Histopathological studies revealed that the circumscribed tumor was composed of a proliferation of atypical epithelioid to spindle-shaped cells with pleomorphic nuclei arranged in haphazard pattern. Histopathological features observed in immunohistochemical analyses confirmed a final diagnosis of UESL. Genome analysis using FoundationOne CDx revealed 11 somatic mutations including TP53 (R196*) and STK11 (F354L). Adjuvant chemotherapy with ifosfamide and etoposide was performed, and the case has been followed up without recurrence for 1 year after hepatectomy. Conclusions: A UESL should be considered in the differential diagnosis of large and well-defined solid liver lesions. Although the prognosis of UESL is extremely unfavorable, aggressive surgical resection with adjuvant chemotherapy and genomic analysis may be helpful for ensuring long-term survival.

26 May 2019 in World Journal of Clinical Cases
Verified
Journal Article
Open access
KKKoichi Kimura
Koichi Kimura
KKKensuke Kudo
Kensuke Kudo
Tomoharu YoshizumiTomoharu Yoshizumi
Tomoharu Yoshizumi
TKTakeshi Kurihara
Takeshi Kurihara
SYShohei Yoshiya
Shohei Yoshiya
TITetsuo Ikeda
Tetsuo Ikeda
In patients with large stones in the common bile duct (CBD), advanced treatment modalities are generally needed. Here, we present an interesting case of a huge CBD stone treated with electrohydraulic lithotripsy (EHL) by the percutaneous approach and rendezvous endoscopic retrograde cholangiography (ERC) using a nasal endoscope. A 91-year-old woman underwent ERC for a symptomatic large CBD stone with a diameter of 50 mm. She was referred to our institution after the failure of lithotomy by ERC, and after undergoing percutaneous transhepatic biliary drainage. We attempted to fragment the stone by transhepatic cholangioscopy using EHL. However, the stones were too large and partly soft clay-like for lithotripsy. Next, we attempted lithotomy with ERC and cholangioscopy by the rendezvous technique using a nasal endoscope and achieved complete lithotomy. No complication was observed at the end of this procedure. Cholangioscopy by rendezvous technique using a nasal endoscope is a feasible and safe endoscopic method for removing huge CBD stones.

6 July 2021 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
JKJunji Kawasaki
Junji Kawasaki
TTTakeo Toshima
Takeo Toshima
Tomoharu YoshizumiTomoharu Yoshizumi
Tomoharu Yoshizumi
SIShinji Itoh
Shinji Itoh
YMYohei Mano
Yohei Mano
MMMasaki Mori
Masaki Mori